EcoRodovias Infraestrutura e Logística S.A (ECOR3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 13.15 |
|---|---|
| 52-week range | 5.84 – 14.87 |
| Return, 1 month / 3 months | +53.1% / +88.9% |
| Return, 1 year / 3 years | +66.5% / +97.8% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 52.3% |
| Worst drawdown (1 year) | -51.8% |
| Average daily value traded | 89.23M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EcoRodovias Infraestrutura e Logística S.A. is a Brazilian infrastructure company based in São Paulo that operates toll road concessions. It manages highway systems in several states, collecting tolls from drivers and freight carriers who use its roads, and it maintains and upgrades the stretches under concession. The company also holds interests in port terminals and logistics operations tied to the movement of cargo. Its customers are mainly motorists, transport companies and businesses that depend on the road network it runs.
EcoRodovias Infraestrutura e Logística S.A trades under the code ECOR3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EcoRodovias Infraestrutura e Logística S.A (ECOR3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 13.15 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 323 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 66.5% and over the last three months it rose 88.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 48.6% | ||
| From 52-week high | -10.8% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 88.9% | ||
| 6-month return | 42.3% | ||
| 12-month return, skipping the last month | 8.7% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 52.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 89.23M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +53.1% |
| 3 months | +88.9% |
| 6 months | +42.3% |
| 1 year | +66.5% |
| 3 years | +97.8% |
| 5 years | +73.0% |
Signals
| 50-day / 200-day average | 8.71 / 8.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Aug 2025 | BRL 0.3087 |
| 13 May 2024 | BRL 0.1945 |
| 14 Nov 2023 | BRL 0.0839 |
| 5 Dec 2022 | BRL 0.0076 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.